Welcome to our dedicated page for TruBridge SEC filings (Ticker: TBRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare IT revenue streams can be notoriously opaque. TruBridge’s mix of recurring revenue cycle management fees, electronic health-record licensing, and patient-engagement services means its SEC filings are packed with deferred-revenue tables, segment footnotes, and complex HIPAA-related risk factors. Investors looking for the real driver behind TruBridge’s margin profile—or clues about new hospital-system contracts—must wade through hundreds of pages. This page puts TruBridge SEC filings explained simply at your fingertips.
You’ll find every document, from the TruBridge annual report 10-K simplified to each TruBridge quarterly earnings report 10-Q filing, updated in real time from EDGAR. Our AI-powered summaries extract RCM metrics, spotlight HIPAA disclosures, and translate accounting jargon into plain language. Need to track management moves? Get TruBridge insider trading Form 4 transactions and TruBridge Form 4 insider transactions real-time the moment they post. Handling breaking news? We have every TruBridge 8-K material events explained within minutes, alongside auditor letters, registration statements, and more.
Use the insights, not just the data. Compare segment revenue trends, monitor TruBridge executive stock transactions Form 4 before material announcements, or review the TruBridge proxy statement executive compensation without endless scrolling. Each filing opens with concise AI highlights, interactive charts, and exportable tables, saving hours of manual work. Whether you need TruBridge earnings report filing analysis or guidance on understanding TruBridge SEC documents with AI, our platform delivers clarity, speed, and confidence.
Insider sale disclosed: The filing shows that David Harse, listed as an officer with the title General Manager Patient Care, reported a sale of 1,744 shares of TruBridge, Inc. (TBRG) on 03/14/2025 at a reported price of $27.40 per share. After the transaction he beneficially owned 18,058 shares, held directly. The form is signed by an attorney by power of attorney on 08/15/2025. No derivative transactions or additional remarks are included in the filing.
TruBridge reported a quarter of positive operating results and improved profitability. Total revenues were $85.7 million for the three months ended June 30, 2025, essentially flat with the prior year period, while the company recorded GAAP net income of $2.58 million for the quarter and $3.04 million for the six months ended June 30, 2025, reversing prior-year losses. Adjusted EBITDA rose to $31.97 million for the six-month period from $23.77 million a year earlier, driven by expense reductions and higher recurring revenue.
The balance sheet shows $12.28 million in cash, total assets of $390.15 million and long-term debt (less current portion) of $163.11 million. Credit losses and financing receivables trends warrant attention: the allowance for credit losses increased to $0.82 million and total financing receivables declined to $2.75 million. The Patient Care reporting unit carries an accumulated goodwill impairment of $35.91 million, and the company is evaluating new tax legislation impacts.
Form 4 Overview: TruBridge, Inc. (TBRG) filed a Form 4 disclosing two routine transactions by President & CEO Christopher L. Fowler, who is also a director.
- July 1, 2024: 1,508 common shares were withheld by the company at $10.57 per share to satisfy tax obligations upon restricted-stock vesting (code “F”).
- July 1, 2025: 2,278 common shares were similarly withheld at $23.48 per share (code “F”).
Following the 2025 withholding, Fowler directly holds 127,304 common shares and indirectly holds 16 shares through his spouse, for a total of 127,320 shares.
Key Takeaways:
- The transactions are not open-market sales; they are non-discretionary tax withholdings, a common administrative action when restricted stock vests.
- No options or other derivative securities were reported.
- Fowler remains a significant insider with over 127k shares, indicating continued alignment with shareholder interests.
FAQ
What is the current stock price of TruBridge (TBRG)?
What is the market cap of TruBridge (TBRG)?
